Zoetis Belgium S.A.
Records under this name other than the patents Zoetis Belgium S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 7 of 7 · Back to Zoetis Belgium S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,354,522 | Immunostimulatory oligoribonucleotides Term ended Term ended Nov 22, 2026 · USPTO record | Term ended | Term ended Nov 22, 2026 | USPTO record |
| US 8,940,271 | Transmucosal Administration of Drug Compositions for Treating and Preventing Disorders in Animals Term ended Term ended Feb 17, 2026 · Medium confidence | Term ended | Term ended Feb 17, 2026 | Medium confidence |
| US 8,658,607 | Immunostimulatory G, U-containing oligoribonucleotides Term ended Term ended May 28, 2024 · USPTO record | Term ended | Term ended May 28, 2024 | USPTO record |
| US 9,428,536 | Immunostimulatory G, U-containing oligoribonucleotides Term ended Ended no later than Apr 4, 2023 · USPTO record | Term ended | Ended no later than Apr 4, 2023 | USPTO record |
| US 6,525,053 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors Term ended Term ended Aug 20, 2018 · USPTO record | Term ended | Term ended Aug 20, 2018 | USPTO record |
| US 7,521,425 | Anti-angiogenic compounds Lapsed on the fee record Ended Apr 21, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2017 | USPTO record |
| US 6,274,715 | Tricyclic erythromycin derivatives Term ended Term ended Jan 7, 2017 · USPTO record | Term ended | Term ended Jan 7, 2017 | USPTO record |